GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » Other Long-Term Liabilities

Nxera Pharma Co (FRA:JSS) Other Long-Term Liabilities : €43.4 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Nxera Pharma Co Other Long-Term Liabilities?

Nxera Pharma Co's other long-term liabilities for the quarter that ended in Sep. 2024 was €43.4 Mil.

Nxera Pharma Co's quarterly other long-term liabilities increased from Mar. 2024 (€37.2 Mil) to Jun. 2024 (€44.6 Mil) but then declined from Jun. 2024 (€44.6 Mil) to Sep. 2024 (€43.4 Mil).

Nxera Pharma Co's annual other long-term liabilities increased from Dec. 2021 (€25.3 Mil) to Dec. 2022 (€54.8 Mil) but then declined from Dec. 2022 (€54.8 Mil) to Dec. 2023 (€38.2 Mil).

Nxera Pharma Co Other Long-Term Liabilities Historical Data

The historical data trend for Nxera Pharma Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Other Long-Term Liabilities Chart

Nxera Pharma Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nxera Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nxera Pharma Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Nxera Pharma Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (FRA:JSS) » Definitions » Other Long-Term Liabilities
Comparable Companies
TSE:4974 TSE:219A TSE:4592 TSE:4894 TSE:190A TSE:4888 TSE:7774 TSE:4599 TSE:4880 TSE:4583 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
SOLTF:USA 4565:Japan
Address
Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052
Website
https://www.nxera.life
Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines